Concerned by the speed of research, regulators – whose job it is to establish the bounds of what is permissible – are looking for alternative ways to establish rules on genome editing and other technologies.
Regulators are struggling to keep up. Peter Thompson, chief executive of the UK Human Fertilisation and Embryology Authority (HFEA), said 'Regulatory approval cannot happen at the same speed as scientific development.'
Philip Ball discuses further in a news feature in Nature.
